Side-Effect Management

ASCO: Guidelines Released for Early Detection, Treatment of Colorectal Cancer

Stratified guidelines emphasize optimal detection methods and treatments of colorectal cancer.

PROMS Tool Revealed Unmet Needs in Care of Resected Colorectal Cancer

By

Susan Moench, PhD, PA-C

A report on pilot groups’ use and evaluation of a PROMS tool for patients who underwent surgical treatment for colorectal cancer showed unmet needs in several domains.

Treatment-Associated Nausea and Vomiting: A Review of Guidelines

By

Bryant Furlow

Most patients undergoing anticancer chemotherapy or radiation therapy will experience treatment-induced nausea and vomiting. But key gaps remain in our understanding of how best to prevent and treat this debilitating adverse effect, leading to inconsistencies among clinical antiemetic guidelines. The available evidence for how best to prevent and manage nausea and vomiting during and following…

Increased Risk of Mental Health Disorders in Colorectal Cancer Survivors

By

Susan Moench, PhD, PA-C

According to researchers, patients diagnosed with a mental health disorder following colorectal cancer diagnosis have an increased risk of death.

Outcome and Prognostic Factors Following Palliative Craniospinal Irradiation for Leptomeningeal Carcinomatosis

[Cancer Management and Research] Researchers report on the efficacy of palliative CSI in alleviating neurologic symptoms or delaying neurologic deterioration in patients with leptomeningeal carcinomatosis.

Uncertainty Common in Primary Family Caregivers of Patients With Multiple Myeloma

By

Susan Moench, PhD, PA-C

Researchers find trends among physical and emotional challenges associated with being the primary family caregiver of a patient with multiple myeloma.

Online Educational Program for Assessment, Management of Cancer Pain Improves Nurse Skills

By

Susan Moench, PhD, PA-C

Knowledge, confidence, and skills related to managing complex cancer pain were improved with a 7-module, online APAM program.

Pretreatment BMI Influences Weight Changes After Adjuvant Chemotherapy for Early-Onset Breast Cancer

By

Susan Moench, PhD, PA-C

Using a cohort of women from the POSH Study, researchers sought to determine risk factors for changes in weight among younger, premenopausal women receiving adjuvant chemotherapy for early-stage breast cancer.

Adverse Events in Randomized Clinical Trials for Targeted Therapies High in Placebo Groups

By

John Schieszer

Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.

Internet-Based CBT Program Improves Management of Menopausal Symptoms in Breast Cancer Survivors

By

Susan Moench, PhD, PA-C

A randomized study sought to determine if an Internet-based cognitive behavioral therapy program focused on managing treatment-induced menopausal symptoms has the potential to help breast cancer survivors adhere to long-term endocrine therapy.